EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies

Seiichiro Takao, Hiroshi Fukushima, Aki Furusawa, Takuya Kato, Shuhei Okuyama, Makoto Kano, Hiroshi Yamamoto, Motofumi Suzuki, Miyu Kano, Peter L Choyke, Hisataka Kobayashi

Cancer Immunology, Immunotherapy · 2025

DOI: 10.1007/s00262-024-03903-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2025. Verfasst von Seiichiro Takao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892, USA. Hauptthemen laut MEDLINE: Thromboplastin, Immunotherapy, Phototherapy, Xenograft Model Antitumor Assays. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue factor (TF) is a cell surface protein that plays a role in blood clotting but is also commonly expressed in many cancers. Recent research implicated TF in cancer proliferation, metastasis, angiogenesis, and immune escape. Therefore, TF can be considered a viable therapeutic target against cancer. Herein, we developed and tested a TF-targeted near-infrared photoimmunotherapy (NIR-PIT) as a potential treatment for several types of cancer. Tisotumab, a TF antibody, was conjugated to IR700. The efficacy of TF-targeted NIR-PIT was investigated using multiple cancer cell lines (A431; epidermoid carcinoma, HPAF-II; pancreatic adenocarcinoma, HSC-2; oral carcinoma, HT1376-luc; bladder carcinoma, MDAMB231; breast adenocarcinoma, and SKOV3-luc; ovarian serous cystadenocarcinoma) in vitro. In vivo, the efficacy of TF-targeted NIR-PIT was evaluated in HPAF-II and A431 xenograft mouse models. Pathologic changes in these tumors after NIR-PIT were evaluated in these tumor models. All cancer lines demonstrated TF expression in vitro and in vivo. Additionally, TF expression was documented to localize to cancer cells in tumors. In vitro, TF-targeted NIR-PIT caused cell death in a light dose-dependent manner. In vivo, TF-targeted NIR-PIT suppressed tumor growth and improved survival rates compared to controls. Furthermore, in vivo NIR-PIT showed histological signs of cancer cell damage, such as cytoplasmic vacuolation, nuclear dysmorphism, and extracellular leakage of LDHA consistent with cell death. In conclusion, TF-targeted NIR-PIT holds promise as a treatment for multiple cancer models expressing TF, spanning multiple cancer types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThromboplastinImmunotherapyPhototherapyXenograft Model Antitumor AssaysHumansAnimalsMiceFemaleNeoplasmsCell Line, TumorInfrared RaysMice, Nude

Stichwörter der Autor:innen

Factor IIINear-infrared photoimmunotherapyPreclinical modelTissue factor

Substanzen

Thromboplastin

Autor:innen und Institutionen

  • Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892, USA.
  • Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, NIH, 10 Center Drive, Bethesda, MD, 20892, USA. kobayash@mail.nih.gov.

Förderung

  • Intramural NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Takao, S., Fukushima, H., Furusawa, A., Kato, T., Okuyama, S., Kano, M., Yamamoto, H., Suzuki, M., Kano, M., Choyke, P. L., & Kobayashi, H. (2025). Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03903-2

Vancouver

Takao S, Fukushima H, Furusawa A, Kato T, Okuyama S, Kano M, et al. Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies. Cancer Immunology, Immunotherapy. 2025. doi:10.1007/s00262-024-03903-2

BibTeX
@article{Takao2025,
  author = {Takao, Seiichiro and Fukushima, Hiroshi and Furusawa, Aki and Kato, Takuya and Okuyama, Shuhei and Kano, Makoto and Yamamoto, Hiroshi and Suzuki, Motofumi and Kano, Miyu and Choyke, Peter L and Kobayashi, Hisataka},
  title = {Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  doi = {10.1007/s00262-024-03903-2}
}
Kostenlos starten →